In a previous paper (1) we have described a method of following the disappearance of intravenously injected colloidal radioactive gold from the circulation in man and have discussed the possibilities of calculating liver blood flow from the disappearance rate constant as the fraction of blood volume perfusing the liver per unit time.
In a previous paper (1) we have described a method of following the disappearance of intravenously injected colloidal radioactive gold from the circulation in man and have discussed the possibilities of calculating liver blood flow from the disappearance rate constant as the fraction of blood volume perfusing the liver per unit time.
If liver blood flow values estimated in this way could be demonstrated to be correct this method should have many advantages over other methods currently in use: it does not require hepatic vein catheterization; with only one blood sample withdrawn for determination of hematocrit and plasma volume, it does not involve any undue blood loss to the patient; being exceedingly simple and mechanized to a considerable extent by the use of counting rate meters and recorders, it can be carried out by a single technician; it can be repeated several times without exposing the patient to any risk thereby enabling observation of changes in hepatic circulation over any period of time.
Hepatic blood flow values estimated by this method in 25 normal subjects (18 males and 7 females) were found to average 1310 ml. per min.
(1) and thus to be somewhat lower but still within the range of normal values reported by other groups who used the bromsulphalein or other methods. However, even this difference might not have been a real one. In this laboratory the observed venous hematocrit is corrected for trapped plasma and for the uneven distribution of cells and plasma within the whole body circulation.
This leads to a blood volume which is about 14 per cent lower than that which is calculated from the uncorrected hematocrit. None with the average normal radiogold results, appear to have used any correction of the hematocrit. It might, therefore, well be that the difference between average hepatic blood flows estimated by these two methods in different groups of normal subjects has been caused by the difference in the methods of calculating blood volume.
However, a few experiments designed to investigate the efficiency of the liver phagocytes to remove the colloid particles from the blood passing through the liver, indicated that the radiogold method underestimates the true hepatic blood flow by almost 20 per cent (1) . If this is true a direct comparison of BSP and radiogold results should reveal a real difference in the calculated flow values. Simultaneous estimations of hepatic blood flow by these two methods were, therefore, performed in 15 subjects the results of which are presented in this paper.
METHODS
Material. The subj ects studied were hospitalized patients in whom for diagnostic purposes a heart or hepatic vein catheterization was warranted. Therefore, none of the subjects could be considered to be "normal."
Catheterization. (1) with the exception that a shielded scintillation counter fitted with a ll X 1 inch thallium-activated sodium iodide crystal was used instead of the lead cathode GMcounter, the opening of the shielding placed close to the skin over one of the thighs. A counting rate meter was used to read off counts per second at intervals of 1 min. and recently an ink-writer was attached to enable automatic recording. Colloidal Au.98 produced by A.E.R.E.,
Harwell, now obtainable with a specific activity of up to 100 mc. per ml., was again used. It might be worthwhile to note that according to Lahr, Olsen, Gleason, and Tabern (3), the American-produced "Aurcoloid" has an average particle size of only about one-fifth of that of the British-made colloidal radiogold and might, therefore, be unsuitable for this type of experiment.
Blood volume. Whole body hematocrit and plasma volume were determined and blood volume was calculated as previously described (1) with the exception that for determination of plasma volume, instead of T-1824, human serum albumin labeled with I"' was used in a few cases.
RESULTS
It will be seen from the data presented in Table  I that hepatic blood flow values estimated by the radiogold method (LMV) were, on the average, (3, 8, 9) indicate that small fractions of the administered dose are picked up by the adrenals, the kidneys, and the bone marrow. In postmortem studies of human subjects given therapeutic doses of the British radiogold intravenously, between 90 and 95 per cent could be accounted for in liver and spleen (10) . It is probable that the remaining fractions are formed by the very small particles which pass the liver and spleen anyway, and whose disappearance curve from the circulation has to be separated graphically from the disappearance curve of the large and medium-sized particles. The error arising from this source should, therefore, be small; moreover, the removal rate of the small particles appears to be several times slower than that of the larger particles (7).
4. The nature of the colloid used is apparently of no importance provided the particle size does not differ greatly. Similar removal rates for different colloids with the exception of yttrium compounds have been observed in various animals (4, (11) (12) (13) . In this laboratory, colloidal iron saccharate labeled with Fe59 has been observed to disappear from the human circulation at rates which did not significantly differ from the disappearance rates of colloidal radiogold (14) . v r- 5 . If the amount of colloidal radiogold injected is kept below 250 Agm., "saturation" of the uptake mechanisms in the liver and spleen is unlikely to occur (1) .
The nature and magnitude of the errors involved in the BSP method are far better known. Throughout this study all efforts were made to follow the procedures of infusing, timing of sample withdrawal, and of measuring BSP plasma concentration described by Bradley, Ingelfinger, Bradley, and Curry (2) as closely as possible. The results of several experiments had to be discarded because either the change in peripheral BSP concentration was too rapid or BSP extraction by the liver was too small, but even in the remaining cases considerable difficulties were encountered in the calculation of EHBF from the BSP data. Though these difficulties may have been aggravated to some extent by the inexperience of the authors with this method, some of the errors appeared to be unavoidable:
1. In most cases a steady state between BSP infusion and BSP removal could not be reached and BSP extraction by the liver decreased steadily during the experiment. Since this decrease was not accompanied by an immediate and corresponding increase in peripheral BSP concentration the calculated EHBF figures rose steadily. Though in some cases hepatic blood flow might have indeed changed it is improbable that it had changed in the same direction and to such an extent in so many cases. Moreover, cardiac output more often decreased than increased during the experiment. Thus, it was quite difficult to decide which of the several EHBF and EBSP values which could be calculated during the period from 10 to 45 min. after starting the infusion, should be taken to come closest to the correct value. As a routine procedure that value was taken which was calculated from a period of time during which peripheral BSP concentration remained constant or nearly so, usually the 25 to 30-min. period. Though in these subjects the increase in peripheral BSP concentration which should follow a fall in BSP extraction in case the flow remains constant, was usually delayed by 5 to 10 min., the authors believe that the fall in calculated EBSP figures was caused by a progressive impairment of the ability of the liver to remove BSP from the circulation. The same mechanism has been shown by Mendeloff, Kramer, Ingelfinger, and Bradley (15) to be responsible for the so-called "saturation effect" which is frequently observed after a single intravenous BSP dose. Even in normal cases the rate of BSP excretion into the bile is consistently below the rate of BSP removal by the liver parenchyma (16, 17) ; since the limiting factor would be the volume of the BSP space within the liver, after some time following injection the removal rate must slow down to the rate of biliary excretion. In cases with hepatic dysfunction it is likely that the biliary excretion rate as well as the volume of the BSP space is decreased and, in fact, the "saturation effect" has been observed more frequently in patients with hepatic disorders (18) (19) (20) . In the present series the "saturation effect" has been seen after a single BSP dose in five cases. The observation that in these cases the differences between the radiogold and the BSP flow values were, on the average, 31 per cent whereas in the cases without "saturation" the average difference was only 8 (2) ; however, it can be assumed that the magnitude of these variations is usually smaller than this maximal value.
6. In restless patients it is sometimes difficult to maintain the tip of the catheter in exactly the same position, and hepatic vein blood may be inadvertently contaminated with inferior vena cava blood. By frequent fluoroscopic controls rigorous attention has to be paid to continually proper placement of the catheter.
Both methods depend on the accuracy of the blood volume determination. In the present study the calculation of both liver blood flow values has been based on the same plasma volume and the same whole body hematocrit; therefore, any error in the estimation of these values cannot be made responsible for the individual differences between the liver blood flow values.
The majority of the known errors of the BSP method appear to lead to an overestimation of the true hepatic blood flow and this has been shown to be true by comparison with direct blood flow determinations performed by Selkurt (22, 23) . From the limited information now available it is most probable that the radiogold method, on the other hand, underestimates the true hepatic blood flow and it seems only surprising that, on the average, the differences between both values observed in the present study have not been greater.
The large individual variations in the direction and the magnitude of the differences could be explained by delays in the assumed rapid mixing of the injected radiogold within the circulation and by variations in the efficiency of splenic and hepatic removal of the colloid material as well as by nonuniform extraction of BSP by the liver. SUM MARY 1. In 15 patients with hepatic or cardiac disorders hepatic blood flow was estimated simultaneously by the bromsulphalein and by the radiogold method.
2. Liver blood flows calculated from the disappearance rate constant of colloidal Au'98 and from the blood volume, were found to average 84.4 per cent of the values obtained by the bromsulphalein method, with large individual variations in the direction and in the magnitude of the differences.
3. The source and magnitude of the errors involved in both methods which may have been responsible for these differences are discussed.
